Jim Simons Soligenix, Inc. Transaction History

Renaissance Technologies LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.4 - $168.0 $560 - $235,200	1,400 Added 2.1%	68,200 $31,000
Q3 2022 Nov 14, 2022	BUY	$0.51 - $117.79 $7,140 - $1.65 Million	14,000 Added 26.52%	66,800 $29,000
Q2 2022 Aug 12, 2022	BUY	$0.4 - $0.75 $6,600 - $12,375	16,500 Added 45.45%	52,800 $32,000
Q1 2022 May 13, 2022	BUY	$0.61 - $0.75 $8,723 - $10,725	14,300 Added 65.0%	36,300 $26,000
Q4 2021 Feb 11, 2022	BUY	$0.66 - $1.1 $14,520 - $24,200	22,000 New	22,000 $15,000
Q3 2021 Nov 12, 2021	SELL	$0.9 - $1.31 $266,499 - $387,905	-296,111 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$0.87 - $1.58 $257,616 - $467,855	296,111 New	296,111 $329,000
Q3 2020 Nov 13, 2020	SELL	$1.7 - $2.61 $304,980 - $468,234	-179,400 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.36 - $2.26 $477,714 - $793,849	-351,261 Reduced 66.19%	179,400 $379,000
Q1 2020 May 14, 2020	BUY	$1.42 - $3.34 $311,647 - $733,029	219,470 Added 70.53%	530,661 $892,000
Q4 2019 Feb 13, 2020	BUY	$0.87 - $1.45 $36,105 - $60,175	41,500 Added 15.39%	311,191 $451,000
Q3 2019 Nov 13, 2019	BUY	$0.72 - $1.31 $28,821 - $52,439	40,030 Added 17.43%	269,691 $256,000
Q2 2019 Aug 12, 2019	BUY	$0.67 - $0.91 $23,651 - $32,123	35,300 Added 18.16%	229,661 $163,000
Q1 2019 May 14, 2019	BUY	$0.88 - $1.04 $11,440 - $13,520	13,000 Added 7.17%	194,361 $178,000
Q4 2018 Feb 13, 2019	BUY	$0.85 - $2.1 $154,156 - $380,858	181,361 New	181,361 $156,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $125M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.